HopeStage
Back to all studies
WithdrawnNCT01155544

Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole

Behavioural studyAges 16–44United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 16 years to 44 years.

Listed locations
Glen Oaks and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJune 2011
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Northwell Health
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioural
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 16 Years to 44 Years
Official registry ID
NCT01155544
Official title
Show the full official title

Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole

Recruitment & locations

Withdrawn

Glen Oaks · Manhasset

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Northwell Health.

Who can participate?

Listed age limits: 16 years to 44 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies